Health
Study reveals mechanisms behind sensitivity of multiple myeloma cells to EZH2 inhibition – News-Medical.net
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma….
Researchers from Uppsala University show in a new study that inhibition of the protein EZH2 can reduce the growth of cancer cells in the blood cancer multiple myeloma. The reduction is caused by changes in the cancer cells’ metabolism. These changes can be used as markers to discriminate whether a patient would respond to treatment by EZH2 inhibition. The study has been published in the journal Cell Death & Disease.
Multiple myeloma is a type of blood cancer where immune cells grow in an uncontrolled…
-
Noosa News24 hours agoBasic cyber steps can block most attacks – Proctor
-
Noosa News18 hours agoWhat instrument did Japan’s heavy-metal PM play? Take the Brisbane Times Quiz
-
Business11 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Noosa News22 hours agoCompetition watchdog approves Elders’ $475m acquisition of agribusiness rival Delta